Wealth Enhancement Advisory Services, LLC Vertex Pharmaceuticals Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 81,246 shares of VRTX stock, worth $35.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
81,246
Previous 73,469
10.59%
Holding current value
$35.3 Million
Previous $28.8 Million
22.55%
% of portfolio
0.05%
Previous 0.05%
Shares
24 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.83MPut Options Held
1.2M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$10.5 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...